Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19.
Read more …Large genetic study on severe COVID-19

Rates of subsequent myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following an acute illness were roughly the same between people whose acute illness was due to COVID-19 and those who did not have COVID-19, a new study finds.
Read more …Research finds no difference in myalgic encephalomyelitis/chronic fatigue syndrome prevalence...

Warning: This article contains graphic images.

Xylazine or “tranq” wounds – characterized by deep pockets of dead tissue – have become increasingly visible in Philadelphia among people who use drugs.

That’s because xylazine[1], an animal tranquilizer with no FDA-approved use in humans, is now pervasive in Philadelphia’s street fentanyl supply[2]. Forensic testing has revealed xylazine’s presence in over 90%[3] of street...

Read more

More Articles …